By blocking the synthesis of FAK they detected the effect of crosstalk between EGFR and integrin signal pathways on the proliferation and invasion in a GC cell line, SGC7901, and proved FAK to be a key cross point of two signaling pathways, which makes it a more effective molecular target for GC therapy.520. The gene discussed is EGFR; the disease is gastric cancer.